Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2026-04-16 @ 2:32 AM
Study NCT ID:
NCT05144061
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2021-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HRS2398-I-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None